Tucatinib is an antineoplastic drug which also comes under the classification of Tyrosine Kinase Inhibitors. This is one of the emerging treatment options for metastatic breast cancer therapy. Tucatinib has a very specific indication applicable for unresectable category of patients where surgery is not an option. HER-Positive confirmation is the key criterion. Its brand name is Tukysa. Seattle Genetics is the company credited for its development and efforts in securing regulatory approvals. Tukysa 50mg and Tukysa 150mg commercial tablets are available in Europe and USA.
Tukysa – Tucatinib regulatory approval status
Patients who received prior anti-HER2-based treatment are eligible for this drug. As per the FDA approval in 2020, Tucatinib can be administered in adult patients in combination with other chemo drugs. The other combination chemotherapy agents are trastuzumab and capecitabine. It is a relatively new product which is yet to be approved in many regions of the world. The EMA approval was also significant which was granted in 2020. Tukysa price in India is dependent on the availability and the regulatory constraints noted from the country of import.
- The clinical trial outcomes are in favor of using Tucatinib in breast cancer patients. As a targeted therapy that inhibits the enzyme kinase, it is effective in arresting the growth of cancer cells. It has a unique mechanism of action. Patients with brain metastasis are also considered eligible for this drug, going by the trial data.
- Tucatinib cost in India will be based on the total quantity required per cycle and recommended treatment duration. Treatment is continued till the time disease progression happens. Dose modifications based on the tolerability are common.
Tucatinib in India – How to procure the drug?
Tucatinib is a very advanced medication that is recommended after careful consideration by an Oncologist. This will be prescribed when other options are exhausted and no credible alternative is available. The challenge however is with its availability. It is not readily available to be purchased from the Indian distribution outlets. Patients should go through the import route with the help of reliable channels to source this drug from counties like Germany or USA. Treating physicians can help with references in many cases.
Indian patients can exercise the legal options available to procure lifesaving medicines. Named Patient import procedure is in place, there are experts who can assist patients. There is no need to panic or undergo unnecessary stress in order to import Tucatinib in India. Better to engage expert professionals who can help in optimizing the right Tukysa cost in India.
Simplified approach to source Tucatinib in India
There are clearly defined systems and processes for procuring or sourcing lifesaving medicines in India. CDSCO is the government portal that allows patients to apply for Import Permits. After securing a legal permit, patients can import Tucatinib in India. These permits are issued for genuine cases where the applications are verified with Dr’s prescription. They are also given for limited quantities with valid timelines. Only reputed companies with access to top global sources should be trusted. Those who are well versed with Indian regulatory and protocols will be of real help when compared with new entities in the market. Make smart decisions based on available choices without delaying the sourcing process.
Contact Noel Biotech – +91 9677010046 / +91 992977766; email@example.com